Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

Rewriting Life

Hard Road for Medical Treatments

Promising studies are often refuted later.

Only a tiny fraction of the compounds tested for different diseases ever make it to clinical trials. Now a report in Science suggests that the results of even encouraging clinical trials are later refuted with surprising frequency.

Scientists from the University of Ioannina School of Medicine in Greece analyzed published studies, from 1990 to 2004, of promising new drug candidates or medical devices. (A sampling is shown at below.) Of 32 interventions described in these papers, each of which had been cited more than 1,000 times, 13 were later shown not to work or to be less effective than originally thought.

Seven of the studies investigated new applications of well-known compounds; of these, six were later refuted. The report concludes that studies of new compounds and devices are a better use of research money.

This story is part of our November/December 2008 Issue
See the rest of the issue
Subscribe

“For common diseases, continuing to play with old agents and interventions is unlikely to give us much hope for finding some major effective intervention that we were not already aware of,” says John Ioannidis, senior author of the study.

Source: John Ioannidis

AI is here.
Own what happens next at EmTech Digital 2019.

Register now
More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Insider Basic.
  • Insider Basic {! insider.prices.basic !}*

    {! insider.display.menuOptionsLabel !}

    Six issues of our award winning print magazine, unlimited online access plus The Download with the top tech stories delivered daily to your inbox.

    See details+

    Print Magazine (6 bi-monthly issues)

    Unlimited online access including all articles, multimedia, and more

    The Download newsletter with top tech stories delivered daily to your inbox

/3
You've read of three free articles this month. for unlimited online access. You've read of three free articles this month. for unlimited online access. This is your last free article this month. for unlimited online access. You've read all your free articles this month. for unlimited online access. You've read of three free articles this month. for more, or for unlimited online access. for two more free articles, or for unlimited online access.